AI

Artificial intelligence is transforming virtually every industry, from healthcare and pharmaceuticals to finance and national security. Yet as adoption accelerates, so does evidence of harm. The Organization for Economic Co-operation and Development (OECD) AI Incidents Monitor (AIM), which tracks publicly reported AI incidents and hazards worldwide now contains more than 16,000 documented incidents and hazards, […]

The European Commission’s newly released draft guidelines (May 2026) on high-risk AI systems mark a pivotal step in operationalizing the EU AI Act. While the Act itself established a risk-based regulatory framework back in 2024, these guidelines provide much-needed clarity on how to determine whether an AI system falls into the “high-risk” category—arguably the most […]

In today’s rapidly evolving technological landscape, pharma and biotech businesses are increasingly looking to leverage artificial intelligence (AI) to gain a competitive edge. However, before diving headfirst into AI, it is crucial to lay a solid foundation. One of the most effective ways to do this is by implementing a Unified Namespace (UNS). This blog […]

Whether you believe synthetic data to be real or fake, the overall market for it is expected to grow from $351.2 million in 2023 to $2,339.8 million by 2030 (Synthetic Data Generation Market Forecast | Fortune Business Insights).  This statistic can make the most hardened cynic’s ears perk up.  But, surely, in our world of regulated medicinal […]